Speaking at the T1D Exchange annual meeting, Glooko Chief Medical Officer Dr. Mark Clements shares how un-siloed health data has the potential to reshape the care provided to people with type 1 diabetes.
-Kelsie LaFerriere The T1D Exchange Registry (hereon referred to as the Registry) is a research study designed to harness the power of people with type 1 diabetes. By completing a questionnaire once a year and opportunities to join other type 1 diabetes research, participants can add their voices, experiences, and data to a body of […]
Check out a live stream of T1D Exchange’s Annual Meeting 2019 in Cambridge, MA: Live Stream The event has featured speakers from the FDA, faculty from our Quality Improvement Collaborative, and more. Join us online for insights, questions, and discussion panels!
The bill would mandate that the government negotiate with drug makers about the price of insulin, both in the Medicare program and for the open insurance market. It also includes many other mechanisms intended to lower the price of insulin and other drugs.
-T1D Exchange staff On September 23rd, T1D Exchange will hold its annual meeting at the Royal Sonesta in Cambridge, Massachusetts. The theme of this year’s meeting is data–and the organization’s commitment to use it alongside collaboration to improve outcomes for individuals with type 1 diabetes. In the keynote address, “The Evolution of Real-World Evidence in […]